Syncona has launched Purespring to commercialise gene therapies aimed at kidney diseases that are based on work at University of Bristol.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Co-founded by a professor emeritus at UC Berkeley, Deep Isolation has secured strategic funding from NAC International for its nuclear waste disposal business.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Chronic illness drug developer Sigilon Therapeutics, co-founded by MIT and UIC researchers, has filed to go public after raising almost $200m in funding.

MIT-founded grid battery spinout Form Energy expects to reveal the round's investors within weeks after it pushed its overall funding to more than $120m.

The University of Cambridge-aligned healthcare and life sciences accelerator has added Novartis as a strategic partner.

Existing backers Takeda, Deerfield and Bay City Capital have provided $10m to help progress research from multiple institutions.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

NYU-founded game training platform developer Statespace has now raised $48m in total, having closed its second round in six months.